Physician profile
Vala Berjis
NPI 1023135761
$2,242.33
in general payments reported to CMS, 2019-2025
18 companies · $179 in 2025
The $179 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $167 · 2020: $267 · 2022: $77.15 · 2023: $931 · 2024: $621 · 2025: $179.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,731.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,731.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $537.76 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $469.07 | 2020-2024 | Fasenra, Airsupra |
| Inari Medical, INC. | $173.34 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Inspire Medical Systems, INC. | $168.87 | 2024 | Inspire |
| Coaptech, INC. | $147.64 | 2023 | Puma System |
| Actelion Pharmaceuticals US, INC. | $146.64 | 2019-2024 | Uptravi, Opsumit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $144.14 | 2023-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2024 | Dupixent |
| Intuitive Surgical, INC. | $117.32 | 2025 | |
| Janssen Pharmaceuticals, INC | $42.12 | 2023 | Xarelto |
| Allergan, INC. | $27.45 | 2020 | |
| Baxter Healthcare | $26.60 | 2022 | |
| United Therapeutics Corporation | $26.23 | 2024 | Tyvaso |
| Abiomed | $22.76 | 2025 | |
| Paratek Pharmaceuticals, INC. | $20.31 | 2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.52 | 2019 | |
| Resmed Corp | $17.17 | 2020 | |
| Electromed, INC. | $15.56 | 2025 | Smartvest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vala Berjis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.